Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019

ZHANG Lina; TANG Yonghe; HE Jun; MA Bingzhi

doi:10.14009/j.issn.1672-2124.2021.03.027

您当前的位置：

首页 >

文章列表页 >

Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019

更新时间：2022-10-08

- Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019
- Vol. 21, Issue 3, Pages: 374-376(2021)
- 作者机构：
  
  中日友好医院药学部
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2021.03.027
  CLC： R288
- Published：2021，
扫描看全文
[1]张丽娜,唐永和,赫军,马秉智.2010年3月至2019年9月我国中成药药品说明书修订通告发布情况及现状分析[J].中国医院用药评价与分析,2021,21(03):374-376+380.

ZHANG Lina, TANG Yonghe, HE Jun, et al. Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019. [J]. 21(3):374-376(2021)
[1]张丽娜,唐永和,赫军,马秉智.2010年3月至2019年9月我国中成药药品说明书修订通告发布情况及现状分析[J].中国医院用药评价与分析,2021,21(03):374-376+380. DOI： 10.14009/j.issn.1672-2124.2021.03.027.

ZHANG Lina, TANG Yonghe, HE Jun, et al. Analysis of Announcement and Current Status of Revision of Drug Instructions of Chinese Traditional Patent Medicine in China from Mar. 2010 to Sept. 2019. [J]. 21(3):374-376(2021) DOI： 10.14009/j.issn.1672-2124.2021.03.027.

摘要

目的:探讨我国中成药药品说明书修订现状

促使中成药药品说明书规范化、合理化。方法:回顾我国药品说明书相关法律法规

查询2010年3月至2019年9月国家药品监督管理部门网站发布的有关中成药药品说明书的公告通知

分析涉及的中成药品种、修订项目等资料

总结中成药药品说明书修订中存在的问题。结果:近10年来国家药品监督管理部门共发布了83个中成药药品说明书修订公告及通知

涉及167个中成药品种

其中处方药66种、非处方药101种;修订项目以禁忌、注意事项、不良反应和增加"警示语"为主。但通过平时工作发现

中成药的药品说明书仍存在着书写不规范、落实情况差、监管力度不够和相关法律法规的约束力不强等情况

对患者的用药安全产生了严重影响。结论:我国中成药药品说明书修订还存在内容缺失等问题

有待进一步完善。

Abstract

OBJECTIVE: To probe into the current status of revision of drug instructions of Chinese traditional patent medicine in China

so as to promote the standardization and rationalization of Chinese traditional patent medicine.METHODS: Relevant laws and regulations of drug instructions in China were reviewed.The announcement on drug instructions of Chinese traditional patent medicine in China published on the website of the State Drug Administration from Mar.2010 to Sept.2019 were collected.Related data of varieties and revision items of Chinese traditional patent medicine were analyzed

and the existing problems in revision of drug instructions of Chinese traditional patent medicine were summarized.RESULTS: In the past 10 years

the State Drug Administration had issued a total of 83 announcements and notices for the revision of drug instructions of Chinese traditional patent medicine

there were 167 varieties of Chinese traditional patent medicine

including 66 kinds of prescription drugs and 101 kinds of over-the-counter drugs.The revision items were mainly taboos

cautions

adverse drug reactions and warning words.However

through daily practice

it was found that there were still some problems in drug instructions of Chinese traditional patent medicine

such as non-standard writing

poor implementation

insufficient supervision and weak binding force of relevant laws and regulations

which had severe impacts on the safety of medication for patients.CONCLUSIONS: The revision of drug instructions of Chinese traditional patent medicine in China still has problems such as missing contents

which need to be further improved.

关键词

中成药药品说明书修订公告分析

Keywords

Chinese traditional patent medicineDrug instructionsAnnouncement of revisionAnalysis

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Statistical Analysis on Application of Chinese Patent Medicine by Western Clinicians in A General Hospital Based on Information System and Questionnaire Survey

Information Annotation in Drug Instructions of Topical Drugs in Dermatology of Eight Children’s Hospitals

Analysis on 1 167 Reports of Adverse Drug Reactions in Shanghai Fifth People’s Hospital,Fudan University from 2017 to 2020

Application of Antibiotics in 20 Medical Institutions in District A of Shanghai from 2014 to 2019

Investigation and Analysis of Clinical Application of Human Albumin Injection in Inpatients of Beijing Hospital from 2019 to 2020

Related Author

ZENG Weixin

ZHANG Xuanqi

DUAN Songleng

LIU Min

NIAN Honglei

CAI Heping

LUO Zhihong

ZHANG Xiaoyan

Related Institution

School of Engineering, China Pharmaceutical University

Beijing Key Laboratory of Evaluation on Clinical Rational Drug Application

Dept.of Pharmacy, Beijing Shijitan Hospital, Capital Medical University

Dept.of Clinical Pharmacy, Anhui Provincial Children’s Hospital

Dept. of Pharmacy,Shanghai Fifth People’s Hospital,Fudan University

⁰